Impact Factor 3.634
2018 JCR, Web of Science Group 2019

Frontiers journals are at the top of citation and impact metrics

Original Research ARTICLE Provisionally accepted The full-text will be published soon. Notify me

Front. Endocrinol. | doi: 10.3389/fendo.2019.00465

Effects of Metformin on TSH Levels and Benign Nodular Goiter Volume in Patients Without Insulin Resistance or Iodine Insufficiency.

 Patricia B. dos Santos1*,  Larissa N. Gertrudes1, Flavia Lucia Conceição1, Bruno M. de Andrade1, Denise P. de Carvalho1,  Mario Vaisman1 and  PATRICIA De FATIMA D. TEIXEIRA1
  • 1Federal University of Rio de Janeiro, Brazil

Objectives: To evaluate the impact of metformin (MTF) use on TSH levels, thyroid volume and volume of benign thyroid nodules (TNs). Additionally, to study if iodine status influences the outcomes.

Methods: A total of 23 euthyroid patients (42 TNs) with benign thyroid nodules, diagnosed by fine needle aspiration biopsy, were randomly assigned to MTF or placebo (P) use for six months. Serum TSH, homeostatic model assessment for insulin resistance (HOMA-IR), and urinary iodine concentrations (UIC) were assessed. Ultrasound was used to evaluate TNs and thyroid volumes (TV) and their variations throughout the study. Diabetic patients, those undergoing levothyroxine replacement, and/or using thyroid- or insulin level-influencing drugs were excluded.

Results: The sample consisted predominantly of patients without IR. Both intervention groups were similar regarding several confounding variables and showed a comparable median UIC. Serum TSH decreased significantly after MTF (-0.21 vs 0.09 mUI/L in the P group; p=0.015). At six months, no significant variations were found between groups with respect to TN volumes, TV, HOMA-IR, or body mass index (BMI). However, a tendency toward enlargement of TV with placebo (16.0%; p=0.09) and a protective effect of MTF on growing TN (OR: 0.25; CI 0.05–1.20) was detected after excluding patients with IR (a lower UIC subgroup). The reduction on TSH levels with MTF maintained in the population without iodine insufficiency (-0.24 vs +0.07 in the P group; p=0.046) and was accentuated in those with excessive or more than adequate UIC (-0.69; p=0.043). A protective effect of MTF on growing TN was suggested (OR:0.11; IC:0.02-0.84) in those with higher UIC.

Conclusions: This study demonstrated that MTF caused a reduction in TSH levels in benign nodular goiter. This effect was more accentuated in patients with higher levels of UIC and was accompanied by a suggested protective effect on TN enlargement.

Keywords: Benign thyroid nodule, thyroid nodule volume, Thyroid volume, Metformin, Insuliin resistance, TSH

Received: 30 Apr 2019; Accepted: 26 Jun 2019.

Edited by:

Michele Marinò, University of Pisa, Italy

Reviewed by:

Mario Rotondi, University of Pavia, Italy
Rosaria M. Ruggeri, University of Messina, Italy  

Copyright: © 2019 dos Santos, Gertrudes, Conceição, de Andrade, de Carvalho, Vaisman and TEIXEIRA. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mx. Patricia B. dos Santos, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, patriciaborges.endocrino@gmail.com